The occurrence of ASCA was higher by 25% in Crohn's disease patients carrying at least one NOD2/CARD15 mutation as compared to the non-carrier ones [46], [47], [48]; however, the ASCA prevalence was also high in this latter group. This evidence concerns the gene NOD2 and Crohn disease.